Nautilus Biotechnology, Inc. (NAUT)
2.74
+0.09
(+3.40%)
USD |
NASDAQ |
Mar 18, 16:00
2.74
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Shareholders Equity (Quarterly) : 156.97M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nephros, Inc. | 10.20M |
| Pyxis Oncology, Inc. | 68.78M |
| ProKidney Corp. | -1.008B |
| Neumora Therapeutics, Inc. | 132.16M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 191.11M |
| Total Liabilities (Quarterly) | 34.14M |
| Debt to Equity Ratio | 0.1912 |
| Current Ratio | 13.33 |
| Net Debt Paydown Yield | 0.13% |